Crossmark

Efficacy and tolerability of somatostatin analogues according to gender in patients with neuroendocrine tumors

Crossref DOI link: https://doi.org/10.1007/s11154-023-09858-6

Published Online: 2023-12-05

Published Print: 2024-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ruggeri, Rosaria M. https://orcid.org/0000-0001-8899-684X
Aini, Irene https://orcid.org/0009-0004-3430-0340
Gay, Stefano https://orcid.org/0000-0003-1596-8762
Grossrubatscher, Erika Maria https://orcid.org/0000-0001-7234-7618
Mancini, Camilla https://orcid.org/0009-0002-1839-133X
Tarsitano, Maria Grazia https://orcid.org/0000-0002-3500-0591
Zamponi, Virginia https://orcid.org/0000-0002-2422-9673
Isidori, Andrea M. https://orcid.org/0000-0002-9037-5417
Colao, Annamaria https://orcid.org/0000-0003-4049-2559
Faggiano, Antongiulio https://orcid.org/0000-0002-9324-3946
,
License Information

Text and Data Mining valid from 2023-12-05

Version of Record valid from 2023-12-05
More Information

Article History

Accepted: 23 November 2023

First Online: 5 December 2023

Declarations

:

: This article does not contain any studies with human participants or animals performed by any of the authors.

: The authors declare no competing interests.